drugset / Trial / NCT00978198

Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers

NCT00978198

Phase 1 Completed 100 enrolled Astellas Pharma Inc
RandomizedParallel-groupSingle-blind

Summary

The purpose of the study is to evaluate the safety and tolerability of ASP1517 after single or multiple oral administration in healthy non-elderly adult male subjects.

Timeline

Start
2009-09
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Roxadustat Small molecule Oral

Indications

No indication recorded.